August 30, 2024
Another Pretty Potent Painkiller Preemption Decision
Drug & Device Law
Litigation attorney Eric Alexander authored a Drug & Device Law blog about the importance of dismissing preempted claims with prejudice in product liability cases. In his analysis of Brashear v. Pacira Pharms., Inc., Mr. Alexander asserts that plaintiffs should not be allowed to repeatedly re-plead around preemption once courts have defined the preempted path and argues that the first time a court dismisses claims as preempted, the dismissal should typically be with prejudice unless the plaintiff promptly amends the complaint as a matter of right.
READ: Another Pretty Potent Painkiller Preemption Decision
READ: Another Pretty Potent Painkiller Preemption Decision
Related Insights
CFPB Preliminary Injunction on Pause: D.C. Circuit Weighs In
What Recipients Need to Know if a Federal Grant Is Terminated by the Government

Podcast - Real Justice for Real People